Vaccinia virus proteins activate human dendritic cells to induce T cell responses in vitro

Vaccine

Volumn 27, Issue 1, 2009, Pages 88-92

  Agrawal, Sudhanshu ^a   Gupta, Sudhir ^a   Agrawal, Anshu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dendritic cells; T cells; Vaccinia virus

Indexed keywords

B7 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RECOMBINANT PROTEIN; SMALLPOX VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINIA VIRUS D13L PROTEIN; VACCINIA VIRUS D8L PROTEIN; VACCINIA VIRUS H3L PROTEIN; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGENICITY; IN VITRO STUDY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; VACCINIA VIRUS;

ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; HUMANS; INTERFERON-GAMMA; T-LYMPHOCYTES; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 56949100221     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.10.031     Document Type: Article

References (26)

1. Fenner F.D.A.H., Arita I., Jezek Z., and Ladnyi I.D. Smallpox and its eradication (1988), World Health Organization, Geneva, Switzerland
2. Lane J.M., and Millar J.D. Risks of smallpox vaccination complications in the United States. Am J Epidemiol 93 April (4) (1971) 238-240
3. Fulginiti V.A., Papier A., Lane J.M., Neff J.M., and Henderson D.A. Smallpox vaccination: a review. Part II. Adverse events. Clin Infect Dis 37 July (2) (2003) 251-271
4. Wollenberg A., and Engler R. Smallpox, vaccination and adverse reactions to smallpox vaccine. Curr Opin Allergy Clin Immunol 4 4 (2004) 271-275
5. Alcami A., and Smith G.L. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71 October (1) (1992) 153-167
6. Smith G.L., Symons J.A., Khanna A., Vanderplasschen A., and Alcami A. Vaccinia virus immune evasion. Immunol Rev 159 October (1997) 137-154
7. Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., et al. Poxviruses and immune evasion. Annu Rev Immunol 21 (2003) 377-423
8. Blanchard T.J., Alcami A., Andrea P., and Smith G.L. Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J Gen Virol 79 May (Pt 5) (1998) 1159-1167
9. Drexler I., Heller K., Wahren B., Erfle V., and Sutter G. Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J Gen Virol 79 May (Pt 2) (1998) 347-352
10. Davies D.H., Liang X., Hernandez J.E., Randall A., Hirst S., Mu Y., et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci USA 102 January (3) (2005) 547-552
11. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 January (6673) (1998) 245-252
12. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van Dyke T., et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171 November (10) (2003) 4984-4989
13. Agrawal A., Kaushal P., Agrawal S., Gollapudi S., and Gupta S. Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells. J Leukoc Biol 81 February (2) (2007) 474-482
14. Agrawal A., Agrawal S., Cao J.N., Su H., Osann K., and Gupta S. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J Immunol 178 June (11) (2007) 6912-6922
15. Jotwani R., Pulendran B., Agrawal S., and Cutler C.W. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro. Eur J Immunol 33 November (11) (2003) 2980-2986
16. Sallusto F., Langenkamp A., Geginat J., and Lanzavecchia A. Functional subsets of memory T cells identified by CCR7 expression. Curr Top Microbiol Immunol 251 (2000) 167-171
17. Gupta S., Bi R., Su K., Yel L., Chiplunkar S., and Gollapudi S. Characterization of naive, memory and effector CD8+ T cells: effect of age. Exp Gerontol 39 April (4) (2004) 545-550
18. Gupta S., Bi R., and Gollapudi S. Central memory and effector memory subsets of human CD4(+) and CD8(+) T cells display differential sensitivity to TNF-α-induced apoptosis. Ann N Y Acad Sci 1050 June (2005) 108-114
19. Fulginiti V.A., Papier A., Lane J.M., Neff J.M., and Henderson D.A. Smallpox vaccination: a review. Part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions. Clin Infect Dis 37 July (2) (2003) 241-250
20. Curtsinger J.M., Schmidt C.S., Mondino A., Lins D.C., Kedl R.M., Jenkins M.K., et al. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells. J Immunol 162 March (6) (1999) 3256-3262
21. Miller J.D., van der Most R.G., Akondy R.S., Glidewell J.T., Albott S., Masopust D., et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28 May (5) (2008) 710-722
22. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., et al. Immune response in mice that lack the interferon-gamma receptor. Science 259 March (5102) (1993) 1742-1745
23. Alcami A., and Smith G.L. Soluble interferon-gamma receptors encoded by poxviruses. Comp Immunol Microbiol Infect Dis 19 September (4) (1996) 305-317
24. Alcami A., and Smith G.L. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol 69 August (8) (1995) 4633-4639
25. da Fonseca F.G., Wolffe E.J., Weisberg A., and Moss B. Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail. J Virol 74 August (16) (2000) 7508-7517
26. Davies D.H., McCausland M.M., Valdez C., Huynh D., Hernandez J.E., Mu Y., et al. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 79 September (18) (2005) 11724-11733